The Evolving Role of Esmolol in Management of Pre-Hospital Refractory Ventricular Fibrillation; a Scoping Review
Introduction: Few studies have described their experience using esmolol, an ultra-short acting β-adrenergic antagonist, in the emergency department (ED) as a feasible adjuvant therapy for the treatment of refractory ventricular fibrillation/pulseless ventricular tachycardia (VF/pVT) out-of-hospital...
Main Authors: | Dennis Miraglia, Lourdes A. Miguel, Wilfredo Alonso |
---|---|
Format: | Article |
Language: | English |
Published: |
Shahid Beheshti University of Medical Sciences
2020-03-01
|
Series: | Archives of Academic Emergency Medicine |
Subjects: | |
Online Access: | https://journals.sbmu.ac.ir/aaem/index.php/AAEM/article/view/553 |
Similar Items
-
Feasibility of prehospital esmolol for refractory ventricular fibrillation
by: Casey Patrick, et al.
Published: (2022-04-01) -
Traumatic Refractory Ventricular Fibrillation Successfully Treated with Intra-Arrest Esmolol
by: Kevin Raymond, et al.
Published: (2021-10-01) -
Temporal trends in the incidence and outcomes of shock-refractory ventricular fibrillation out-of-hospital cardiac arrest
by: Abdulrahman Alhenaki, et al.
Published: (2024-06-01) -
Extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest: a scoping review
by: Dennis Miraglia, et al.
Published: (2021-02-01) -
The first case series analysis on efficacy of esmolol injection for in-hospital cardiac arrest patients with refractory shockable rhythms in China
by: Rui Lian, et al.
Published: (2022-09-01)